Target-Controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study compares the manual administration of propofol and remifentanil and their delivery using a combined closed-loop anesthesia system, entropy of the EEG being the controler.
| Condition | Intervention | Phase |
|---|---|---|
|
Anesthesia, General |
Device: Closed-loop anesthesia system |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Target-Controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy of the Electroencephalogram: Comparison Between Manual Perfusion and Automated Perfusion |
- Global score (calculated parameter which depicts the performance of the system, i.e. its capacity to maintain BIS in the desired range)
- consumption of propofol and remifentanil during the induction and the maintenance of the anaesthesia
- number of modifications of target of propofol and remifentanil
- number of episodes of hemodynamic anomalies having required a treatment
- intraoperative volume loading and transfusion
- extubation time, explicit memorisation
- dysfunctions of each system
| Estimated Enrollment: | 60 |
| Study Start Date: | September 2006 |
| Study Completion Date: | April 2007 |
Several monitors are currently proposed to evaluate the depth of hypnosis. Among them, Bispectral Index (BIS) is a well known and widely used parameter derived from the patient’s electroencephalograph (EEG). A closed-loop anesthesia system can be built using BIS as the control variable, a proportional–integral–differential control algorithm, a propofol and a remifentanil target-controlled infusion systems as the control actuators Preliminary results show that this system can be used during surgery.
Spectral entropy relies on the extent of disorder in both EEG and electromyography (EMG) signals and returns 2 values: State Entropy (SE) and Response Entropy. SE is computed over the frequency range of 0.8–32 Hz and reflects the level of hypnosis while Response Entropy is computed over the frequency range of 0.8–47 Hz and reflects also EMG activity. BIS and SE are dimensionless numbers scaled from 100 to 0 for BIS and from 91 to 0 for SE. We hypothesized that SE can be used as the control variable. In preparation for a large multi-center control trial, we propose a prospective randomized study to evaluate the effectiveness of such a closed-loop anesthesia system. Two groups of patients are compared: one in which propofol and remifentanil are administered by the anesthesiologist using target-controlled infusion systems, and one in which propofol and remifentanil are administered automatically by the combined closed-loop anesthesia system. In both groups, the goal is to maintain SE between 40 and 60, the recommended range during anesthesia by the manufacturer. We expect the combined closed-loop anesthesia system group to do similar or better.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- American Society of Anesthesiologists physical status 1-3,
- surgery under general anesthesia using relaxant agent,
- surgery lasting more than one hour
Exclusion Criteria:
- pregnant women,
- indication for rapid sequence induction,
- anticipation of difficult intubation,
- allergy to propofol or remifentanil,
- neurological or muscular disorder,
- combination of general anesthesia and of regional anesthesia,
- emergency surgery
Contacts and Locations| France | |
| Dept of Anesthesia and Intensive Care, Hôpital Beaujon | |
| Clichy, France, 92110 | |
| Dept of Anesthesiology, Hôpital Foch | |
| Suresnes, France, 92150 | |
| Study Chair: | Marc Fischler, MD | Hôpital Foch |
| Principal Investigator: | Marc Fischler, MD | Hôpital Foch |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00391885 History of Changes |
| Other Study ID Numbers: | Foch-4 |
| Study First Received: | October 24, 2006 |
| Last Updated: | April 21, 2007 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Additional relevant MeSH terms:
|
Anesthetics Propofol Remifentanil Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses |
Anesthetics, Intravenous Anesthetics, General Hypnotics and Sedatives Analgesics, Opioid Analgesics Sensory System Agents Peripheral Nervous System Agents |
ClinicalTrials.gov processed this record on May 23, 2013